Dechra Pharmaceuticals PLC (Dechra) is a holding company. The Company operates in three segments: Product Development, European Pharmaceuticals and US Pharmaceuticals. European Pharmaceuticals markets and sells pharmaceuticals and specialist pet foods to the veterinary profession in Europe. It comprises Dechra Veterinary Products Europe and Dechra manufacturing. US Pharmaceuticals markets and sells a range of endocrine, ophthalmic, dermatological and equine products into North America. It includes Dechra Veterinary Products US. In August 2013, the Company announced that it has completed the disposal of the Services Segment. In August 2013, Patterson Companies Inc completed acquisition of the stock of National Veterinary Services Limited, a wholly owned subsidiary of Dechra Pharmaceuticals PLC.